AI assistant
USCOM LIMITED — Regulatory Filings 2015
May 19, 2015
65979_rns_2015-05-19_39949117-8fc3-47b3-8f57-e15cdbe1c005.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au
M A R K E T A N N O U N C E M E N T
USCOM Recognised by China National ICU Society
Sydney, Australia: Wednesday, 20[th ] May 2015: Uscom (ASX code: UCM) (the Company or Uscom ), a revenue stage, cardiovascular medical technology company and manufacturer of premium cardiovascular technologies, is pleased to announce the China National Intensive Care Unit (ICU) Society have included USCOM 1A in their national survey of clinical member current practices and that it was the only non-invasive haemodynamic monitor included.
Only four monitoring methods in total were named; three based on invasive catheter measurements and the non-invasive USCOM 1A. The shift from less accurate invasive monitoring to accurate non-invasive cardiovascular monitoring is a worldwide trend and has been an objective of Uscom since conception. A reduction in use of expensive catheters is also seen as a means to reduce the incidence of catheter associated infections.
In China, the USCOM 1A is recognised as the emerging technology for advanced haemodynamic practice, and while global adoption of the USCOM 1A is increasing, China is advanced in adoption of noninvasive technologies and is looking to the USCOM 1A.
There are approximately 200 USCOM 1As currently installed in China. There are 10,000 ICUs in China and each ICU potentially requires 3 to 5 USCOM units. This National Survey by the China National ICU Society will provide a marketing springboard for USCOM sales into China.
The USCOM 1A received a 5 year CFDA approval in February 2015.
Uscom CEO, Associate Professor Rob Phillips said, “Uscom has been in China for a number of years and have established deep clinical, academic and distribution relationships. China is keen to lead the world in clinical medicine and healthcare delivery, and is very focused on adopting the best technology and developing best clinical practices, and Uscom is pleased to be a part of this growth. The ICU is the missionary market for USCOM 1A, and this recognition shows the impact we are having at the top levels of ICU practice in China. We expect that, with this recognition by the China National ICU Society this early adoption will accelerate into general and widespread practice, a shift that bodes well for future sales."
About Uscom
Uscom Limited (UCM) is an ASX listed cardiovascular medical device company. Uscom is an innovative developer and manufacturer of premium cardiovascular devices and has two practice leading technologies in the field of cardiovascular monitoring, the USCOM 1A and the Uscom BP+. Both devices are clinically validated with FDA, CE and TGA regulatory registration, and are currently being marketed into global distribution networks.
The USCOM 1A is a simple, cost-effective and non-invasive device that measures heart function, detects circulatory abnormalities and guides treatment. The USCOM 1A device has major applications in Paediatrics, Emergency, Intensive Care Medicine and Anaesthesia, and is the device of choice for management of adult and paediatric sepsis, heart failure, and for the guidance of fluid therapy.
The Uscom BP+ is a supra systolic Central Blood Pressure monitor and replaces older and more widespread sub systolic Blood Pressure monitoring technology. Central Blood Pressure is emerging as the new standard of care in hypertension and heart failure. The Uscom BP+ provides a highly accurate and repeatable measurement of central and brachial blood pressure and arterial pulse pressure waveforms, measures otherwise only available by cardiac catheterisation. The Uscom BP+ is simple to use and measures from a familiar upper arm cuff, and requires no complex training, and has applications in cardiology, intensive care, general practice and home care. For more information, please visit: www.uscom.com.au
Uscom Contacts
Assoc. Professor Rob Phillips Executive Chairman [email protected]
Catherine Officer Company Secretary [email protected]